EXAS
insider transactionsEXACT SCIENCES CORP — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
SVP, General Counsel & Sec
—
20.3K sh
Own -100%
-
Other·D
SVP, General Counsel & Sec
—
2.9K sh
Own -100%
-
Other·D
SVP, General Counsel & Sec
—
793 sh
Own -100%
-
Other·D
SVP, General Counsel & Sec
—
1.8K sh
Own -100%
-
Other·D
SVP, General Counsel & Sec
—
68.2K sh
Own -100%
-
Other·D
EVP, GM, Screening
—
38.7K sh
Own -100%
-
Other·D
EVP, GM, Screening
—
6.6K sh
Own -100%
-
Other·D
EVP, GM, Screening
—
1.8K sh
Own -100%
-
Other·D
EVP, GM, Screening
—
153.7K sh
Own -100%
-
Grant·A
EVP, GM, Screening
$0
53.3K sh
Own +53%
-
Other·D
Director
—
7.1K sh
Own -100%
-
Other·D
Director
—
5.4K sh
Own -100%
-
Other·D
Director
—
16.4K sh
Own -75%
-
Other·D
Director
—
5.4K sh
Own -100%
-
Other·D
Director
—
55.4K sh
Own -91%
-
Other·D
Director
—
9.7K sh
Own -100%
-
Other·D
Director
—
6.7K sh
Own -41%
-
Other·D
Director
—
13.9K sh
Own -100%
-
Other·D
Director
—
3.2K sh
Own -19%
-
Other·D
Director
—
5.4K sh
Own -100%
-
Other·D
Director
—
52.6K sh
Own -91%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
154.8K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
83.4K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
44.3K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
18.1K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
100.9K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
34.1K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
66.0K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
235.4K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
117.4K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
86.8K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
46.5K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
29.1K sh
Own -100%
-
Other·D
Kevin T Conroy KEY
President and CEO
—
1.4M sh
Own -100%
-
Grant·A
Kevin T Conroy KEY
President and CEO
$0
119.3K sh
Own +9%
-
Other·D
EVP, Human Resources
—
23.2K sh
Own -100%
-
Other·D
EVP, Human Resources
—
6.6K sh
Own -100%
-
Other·D
EVP, Human Resources
—
7.8K sh
Own -100%
-
Other·D
EVP, Human Resources
—
11.7K sh
Own -100%
-
Other·D
EVP, Human Resources
—
21.9K sh
Own -100%
-
Other·D
EVP, Human Resources
—
6.4K sh
Own -100%
-
Other·D
EVP, Human Resources
—
191.9K sh
Own -100%
-
Grant·A
EVP, Human Resources
$0
60.4K sh
Own +46%
-
Other·D
Director
—
12.9K sh
Own -100%
-
Other·D
Director
—
10.8K sh
Own -100%
-
Other·D
Director
—
4.2K sh
Own -100%
-
Other·D
Director
—
4.7K sh
Own -100%
-
Other·D
Director
—
5.4K sh
Own -100%
-
Other·D
Director
—
52.2K sh
Own -91%
-
Other·D
Aaron Bloomer KEY
EVP, Chief Financial Officer
—
28.1K sh
Own -100%
-
Other·D
Aaron Bloomer KEY
EVP, Chief Financial Officer
—
4.4K sh
Own -100%
-
Other·D
Aaron Bloomer KEY
EVP, Chief Financial Officer
—
417 sh
Own -100%
-
Other·D
Aaron Bloomer KEY
EVP, Chief Financial Officer
—
138.7K sh
Own -100%
-
Grant·A
Aaron Bloomer KEY
EVP, Chief Financial Officer
$0
89.9K sh
Own +184%
-
Other·D
EVP, GM, Precision Oncology
—
28.1K sh
Own -100%
-
Other·D
EVP, GM, Precision Oncology
—
795 sh
Own -100%
-
Other·D
EVP, GM, Precision Oncology
—
137.2K sh
Own -100%
-
Grant·A
EVP, GM, Precision Oncology
$0
33.3K sh
Own +32%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
27.8K sh
Own +50%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
22.2K sh
Own +100%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
18.1K sh
Own New
-
Other·F
Kevin T Conroy KEY
President and CEO
$1.3M
13.1K sh · $103.25
Own -1%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
27.8K sh
Own +2%
-
Other·F
Kevin T Conroy KEY
President and CEO
$1.1M
10.4K sh · $103.25
Own -1%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
22.2K sh
Own +2%
-
Other·F
Kevin T Conroy KEY
President and CEO
$880.5K
8.5K sh · $103.25
Own -1%
-
Exercise·M
Kevin T Conroy KEY
President and CEO
$0
18.1K sh
Own +1%
-
Exercise·M
EVP, Human Resources
$0
3.9K sh
Own New
-
Other·F
EVP, Human Resources
$197.8K
1.9K sh · $103.38
Own -1%
-
Exercise·M
EVP, Human Resources
$19.6K
3.9K sh · $5.03
Own +3%
-
Grant·A
EVP, GM, Screening
$0
38.7K sh
Own New
-
Grant·A
SVP, General Counsel & Sec
$0
20.3K sh
Own New
-
Grant·A
Kevin T Conroy KEY
President and CEO
$0
154.8K sh
Own New
-
Other·F
Kevin T Conroy KEY
President and CEO
$641.0K
6.2K sh · $103.45
Own -0%
-
Grant·A
Kevin T Conroy KEY
President and CEO
$0
13.2K sh
Own +1%
-
Grant·A
EVP, Human Resources
$0
23.2K sh
Own New
-
Grant·A
Aaron Bloomer KEY
EVP, Chief Financial Officer
$0
28.1K sh
Own New
-
Grant·A
EVP, GM, Precision Oncology
$0
28.1K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 23, 2026 | James Herriott | Other D | 20.3K | — |
| Mar 23, 2026 | James Herriott | Other D | 2.9K | — |
| Mar 23, 2026 | James Herriott | Other D | 793 | — |
| Mar 23, 2026 | James Herriott | Other D | 1.8K | — |
| Mar 23, 2026 | James Herriott | Other D | 68.2K | — |
| Mar 23, 2026 | Jacob A Orville | Other D | 38.7K | — |
| Mar 23, 2026 | Jacob A Orville | Other D | 6.6K | — |
| Mar 23, 2026 | Jacob A Orville | Other D | 1.8K | — |
| Mar 23, 2026 | Jacob A Orville | Other D | 153.7K | — |
| Mar 23, 2026 | Jacob A Orville | Grant A | 53.3K | $0 |
| Mar 23, 2026 | Shacey Petrovic | Other D | 7.1K | — |
| Mar 23, 2026 | Shacey Petrovic | Other D | 5.4K | — |
| Mar 23, 2026 | Shacey Petrovic | Other D | 16.4K | — |
| Mar 23, 2026 | Katherine S Zanotti | Other D | 5.4K | — |
| Mar 23, 2026 | Katherine S Zanotti | Other D | 55.4K | — |
| Mar 23, 2026 | Kimberly J Popovits | Other D | 9.7K | — |
| Mar 23, 2026 | Kimberly J Popovits | Other D | 6.7K | — |
| Mar 23, 2026 | Leslie Trigg | Other D | 13.9K | — |
| Mar 23, 2026 | Leslie Trigg | Other D | 3.2K | — |
| Mar 23, 2026 | James Edward Doyle | Other D | 5.4K | — |
| Mar 23, 2026 | James Edward Doyle | Other D | 52.6K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 154.8K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 83.4K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 44.3K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 18.1K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 100.9K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 34.1K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 66.0K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 235.4K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 117.4K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 86.8K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 46.5K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 29.1K | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Other D | 1.4M | — |
| Mar 23, 2026 | Kevin T Conroy KEY | Grant A | 119.3K | $0 |
| Mar 23, 2026 | Sarah Condella | Other D | 23.2K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 6.6K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 7.8K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 11.7K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 21.9K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 6.4K | — |
| Mar 23, 2026 | Sarah Condella | Other D | 191.9K | — |
| Mar 23, 2026 | Sarah Condella | Grant A | 60.4K | $0 |
| Mar 23, 2026 | Scott D Coward | Other D | 12.9K | — |
| Mar 23, 2026 | Scott D Coward | Other D | 10.8K | — |
| Mar 23, 2026 | Scott D Coward | Other D | 4.2K | — |
| Mar 23, 2026 | Scott D Coward | Other D | 4.7K | — |
| Mar 23, 2026 | Scott D Coward | Other D | 5.4K | — |
| Mar 23, 2026 | Scott D Coward | Other D | 52.2K | — |
| Mar 23, 2026 | Aaron Bloomer KEY | Other D | 28.1K | — |
| Mar 23, 2026 | Aaron Bloomer KEY | Other D | 4.4K | — |
| Mar 23, 2026 | Aaron Bloomer KEY | Other D | 417 | — |
| Mar 23, 2026 | Aaron Bloomer KEY | Other D | 138.7K | — |
| Mar 23, 2026 | Aaron Bloomer KEY | Grant A | 89.9K | $0 |
| Mar 23, 2026 | Brian Baranick | Other D | 28.1K | — |
| Mar 23, 2026 | Brian Baranick | Other D | 795 | — |
| Mar 23, 2026 | Brian Baranick | Other D | 137.2K | — |
| Mar 23, 2026 | Brian Baranick | Grant A | 33.3K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 27.8K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 22.2K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 18.1K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Other F | 13.1K | $1.3M |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 27.8K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Other F | 10.4K | $1.1M |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 22.2K | $0 |
| Feb 27, 2026 | Kevin T Conroy KEY | Other F | 8.5K | $880.5K |
| Feb 27, 2026 | Kevin T Conroy KEY | Exercise M | 18.1K | $0 |
| Feb 27, 2026 | Sarah Condella | Exercise M | 3.9K | $0 |
| Feb 27, 2026 | Sarah Condella | Other F | 1.9K | $197.8K |
| Feb 27, 2026 | Sarah Condella | Exercise M | 3.9K | $19.6K |
| Feb 25, 2026 | Jacob A Orville | Grant A | 38.7K | $0 |
| Feb 25, 2026 | James Herriott | Grant A | 20.3K | $0 |
| Feb 25, 2026 | Kevin T Conroy KEY | Grant A | 154.8K | $0 |
| Feb 25, 2026 | Kevin T Conroy KEY | Other F | 6.2K | $641.0K |
| Feb 25, 2026 | Kevin T Conroy KEY | Grant A | 13.2K | $0 |
| Feb 25, 2026 | Sarah Condella | Grant A | 23.2K | $0 |
| Feb 25, 2026 | Aaron Bloomer KEY | Grant A | 28.1K | $0 |
| Feb 25, 2026 | Brian Baranick | Grant A | 28.1K | $0 |
About EXAS insider trading
This page tracks insider transactions for EXACT SCIENCES CORP (EXAS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.